SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-296537
Filing Date
2022-12-01
Accepted
2022-12-01 16:16:34
Documents
14
Period of Report
2022-11-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d431190d8k.htm   iXBRL 8-K 50440
2 EX-3.1 d431190dex31.htm EX-3.1 27551
3 EX-3.2 d431190dex32.htm EX-3.2 47502
  Complete submission text file 0001193125-22-296537.txt   282649

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA akus-20221130.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE akus-20221130_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akus-20221130_pre.xml EX-101.PRE 12144
8 EXTRACTED XBRL INSTANCE DOCUMENT d431190d8k_htm.xml XML 3662
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-410-1818
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-39343 | Film No.: 221439016
SIC: 2834 Pharmaceutical Preparations